The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Non-Profit Shares Concerns with FDA on Avastin Breast Cancer Recommendation

December 16, 2010 8:32 pm | News | Comments

ARDMORE, Pa., Dec. 16, 2010 /PRNewswire-USNewswire/ -- Dr. Marisa Weiss, president and founder of and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to...


U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels

December 16, 2010 4:36 pm | News | Comments

WAYNE, N.J., Dec. 16, 2010 /- Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate...


Zimmer Holdings to Present at 29th Annual J.P. Morgan Healthcare Conference

December 16, 2010 4:35 pm | News | Comments

WARSAW, Ind., Dec. 16, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 10, 2011, at 12 p.m. Eastern Time. A...


Avastin (bevacizumab): Process for Removal of Breast Cancer Indication Begun(2)

December 16, 2010 2:31 pm | News | Comments

FDA recommending removing the breast cancer indication for Avastin because the drug has not been shown to be safe and effective for that use.


Avastin (bevacizumab): Process for Removal of Breast Cancer Indication Begun

December 16, 2010 2:30 pm | News | Comments

FDA recommending removing the breast cancer indication for Avastin because the drug has not been shown to be safe and effective for that use.

Cigna completes offer, buys $169 million in notes(2)

December 16, 2010 1:46 pm | News | Comments

Health care benefit provider Cigna Corp. said Thursday it completed a tender offer for up to $300 million of 6.35 percent senior notes due in 2018.Cigna said it will purchase $169.3 million in notes that were tendered by the Dec. 15 expirationCigna shares fell 49 cents to close Thursday at...

Elsevier Foundation announces 2010 grants for libraries in developing countries

December 16, 2010 12:36 pm | News | Comments

(Elsevier) The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260...


Road to a safer future

December 16, 2010 12:35 pm | News | Comments

(EUREKA) A successful collaborative effort between researchers and industry partners has led to the development of an automated and robust traffic surveillance system, which could make road travel across Europe safer for all.


Ensign Group raises dividend to 5.5 cents

December 16, 2010 10:45 am | News | Comments

The Ensign Group Inc., which runs nursing homes and assisted living centers, said on Thursday that it will pay a quarterly dividend of 5.5 cents per share on Jan. 31 to shareholders of record Dec. 31.The dividend is an increase from the 5 cents per share it had paid previously. The company said...

Perspectives on Time to Market—Part 1

December 16, 2010 10:33 am | Cirtec Medical Systems, Boyd Coatings Research, Inc. | Articles | Comments

For your area of the industry, what is your best recommendation for getting a medical device to market faster? Heather Dunn, Director of Engineering, CIRTEC Medical Systems: CIRTEC Medical Systems is commonly requested to perform accelerated product developments for our clients. The CIRTEC approach in those situations involves a few key tactics.


<i>Blog: </i>Serendipity of HIV cure awaits followup

December 16, 2010 10:32 am | News | Comments

Michelle Lang blogs: The latest case of scientific serendipity comes from widely reported news in Berlin that an HIV positive patient being treated for leukemia with a stem cell transplant has been “cured” of HIV. This initial find opens doors to research and, heck, even to industry.

ActiveO Pursues Copyright, Trademark Infringement Action Against Medtronic

December 16, 2010 9:45 am | News | Comments

After unsuccessful attempts to settle a copyright/trademark infringement dispute out of court, ActiveO, Inc., an Incline Village, Nevada corporation, announced today it filed litigation against Medtronic, Inc., on October 13, 2010. The case was filed in Federal Court in Salt Lake City for...

Athenahealth enlarges e-health records board

December 16, 2010 9:38 am | News | Comments

Athenahealth Inc. has enlarged its board to nine seats from eight. The Watertown-based maker of electronic health records and other health information technology products, has added David E. Robinson to its board.

Capital Improvements Positioning East Coast's Intermodal Rail Network For Increased Container Traffic

December 16, 2010 9:38 am | News | Comments

After having grown used to losing market share in the nation’s container traffic to their West Coast rivals, the East Coast ports and their railroad allies anticipate that the competitive balance will soon shift in their favor.The major catalyst

Sensirion wins ?Entrepreneur of the Year®? Award

December 16, 2010 9:38 am | News | Comments

Sensirion is ?Entrepreneur of the Year® 2010?: Moritz Lechner und Felix Mayer, founders and managing directors of Sensirion, won the title in the category ?High-Tech/Lifescience?. This renowned prize is awarded by Ernst & Young.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.